Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
This antibody is covered by our Worry-Free Guarantee.

Figure: Specificity of PAb to TRAIL-R2. Lane 1: TRAIL-R3:Fc. Lane 2: TRAIL-R2. ALX-210-743 recognizes a band of approx. 46kDa of the expected size of the recombinant TRAIL-R2:Fc protein in lane 2 and shows no detectable cross-reactivity to TRAIL-R3:Fc in lane 1.”””,TRAIL-R2 polyclonal antibody WB,TRAIL-R2 polyclonal antibody Western Blot,yes
ALX-210-744,210-744.gif,http://static.enzolifesciences.com/fileadmin/files/image/210-744.gif,Figure: Specificity of PAb to TRAIL-R3. Lane 1: TRAIL-R3:Fc. Lane 2: TRAIL-R2. ALX-210-744 recognizes an approx. 66kDa band of the expected size of the recombinant TRAIL-R3:Fc protein in lane 1 and shows no detectable cross-reactivity to TRAIL-R2:Fc in lane 2.”””””

Product Details
Alternative Name |
TRAIL receptor 2, DR5, Death receptor 5, KILLER, CD262, Trick2, Ly98, TNFRSF10B, TNF-related apoptosis-inducing ligand receptor 2, Tumor necrosis factor receptor superfamily member 10B |
---|---|
Application |
Flow Cytometry, ICC, IHC (PS), WB |
Application Notes |
Detects a band of ~52kDa by Western blot. |
Formulation |
Liquid. In PBS containing 1mg/ml BSA and 0.1% sodium azide. |
Gene/Protein Identifier |
8795 (Entrez GeneID) |
Host |
Goat |
Immunogen |
Synthetic peptide corresponding to aa 68-94 (A68PQQKRSSPSEGLCPPGHHISEDGRDC94) of the extracellular domain of human TRAIL-R2. |
Purity Detail |
Epitope-affinity purified IgG. |
Quality Control |
Western Blot or Immunocytochemistry on cell lines HEK 293 or Jurkat. |
Recommendation Dilutions/Conditions |
Immunocytochemistry (1:300)Immunohistochemistry (paraffin sections)Western Blot (1:1,000)Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application. |
Species Reactivity |
Human, Mouse |
UniProt ID |
O14763 |
Worry-free Guarantee |
This antibody is covered by our Worry-Free Guarantee. |
Handling & Storage
Handling |
For maximum product recovery after thawing, centrifuge the vial before opening the cap. Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C. |
---|---|
Short Term Storage |
+4°C |
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Homocysteine potentiates amyloid β -induced death receptor 4- and 5-mediated cerebral endothelial cell apoptosis, blood brain barrier dysfunction and angiogenic impairment: Carey, A., Parodi-Rullán, R. M., et al.; Aging Cell 23, e14106 (2024), Abstract
- HOMOCYSTEINE POTENTIATES AMYLOID β-INDUCED CEREBRAL ENDOTHELIAL CELL APOPTOSIS, BLOOD BRAIN BARRIER DYSFUNCTION AND ANGIOGENIC IMPAIRMENT: Carey, A., Parodi-Rullán, R., et al.; bioRxiv , (2023), Application(s): WB
- Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.: Cinatl, J., Michaelis, M., et al.; Oncol. Rep. 43, 1331 (2020), Application(s): WB / Reactant(s): Human, Abstract
- Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL: A. Meijer, et al.; Br. J. Cancer 109, 2685 (2013), Application(s): WB / Reactant(s) Human, Abstract — Full Text
- Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells: J.J. Chen, et al.; Oncotarget 3, 833 (2012), Application(s): IHC, Abstract — Full Text
- Death receptor 5 signaling promotes hepatocyte lipoapoptosis: S.C. Cazanave, et al.; J. Biol. Chem. 286, 39336 (2011), Application(s): Used for IP and ICC, Abstract
- Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer: B. Yoldas, et al.; Head Neck 33, 1278 (2011), Abstract
- Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis: O. Kutlu, et al.; Int. Urol. Nephrol. 42, 393 (2010), Abstract
- Effects of androgen ablation therapy in TRAIL death ligand and its receptors expression in advanced prostate cancer: I.T. Koksal, et al.; Urol. Int. 84, 445 (2010), Abstract
- Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma: K.H. Lee, et al.; Langenbecks Arch. Surg. 394, 661 (2009), Abstract
- High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas: A.D. Sanlioglu, et al.; Pancreas 36, 385 (2008), Abstract — Full Text
- Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas: V. Granci, et al.; Eur. J. Cancer 44, 2312 (2008), Abstract
- Differential expression of TRAIL and its receptors in benign and malignant prostate tissues: A.D. Sanlioglu, et al.; J. Urol. 177, 359 (2007), Abstract
- Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity: H. Malhi, et al.; Gut 56, 1124 (2007), Application(s): WB / Reactant(s) Rat, Abstract — Full Text
- TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma: A.D. Sanlioglu, et al.; Int. J. Radiat. Oncol. Biol. Phys. 69, 716 (2007), Abstract
- Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs: T.M. Ganten, et al.; Cell Death Differ. 11 Suppl 1, S86 (2004), Abstract
- Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5: T.G. Jin, et al.; J. Biol. Chem. 279, 55594 (2004), Reactant(s) Human, Abstract — Full Text
- Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis: H. Higuchi, et al.; J. Biol. Chem. 278, 454 (2003), Abstract — Full Text
- The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis: H. Higuchi, et al.; J. Biol. Chem. 276, 38610 (2001), Abstract — Full Text
- Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy: A.M. Chinnaiyan, et al.; PNAS 97, 1754 (2000), Abstract — Full Text
Related Products

Alternative Name | TRAIL receptor 2, DR5, Death receptor 5, KILLER, CD262, Trick2, Ly98, TNFRSF10B, TNF-related apoptosis-inducing ligand receptor 2, Tumor necrosis factor receptor superfamily member 10B |
---|---|
Application | Flow Cytometry, IHC (PS) |
Host | Mouse |
Isotype | IgG1 |
Species Reactivity | Human |

Alternative Name | TRAIL receptor 2, DR5, Death receptor 5, KILLER, CD262, Trick2, Ly98, TNFRSF10B, TNF-related apoptosis-inducing ligand receptor 2, Tumor necrosis factor receptor superfamily member 10B |
---|---|
Application | Flow Cytometry |
Host | Mouse |
Isotype | IgG1 |
Species Reactivity | Human |
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form